Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR−/− Mouse Strain

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR−/− Mouse Strain

Aims. Hyperlipidaemia model animals have been used to elucidate the role of Chlamydia pneumoniae (Cpn) infection in atherosclerosis. The aims of this study were to investigate the proatherogenic effect of multiple Cpn infections in ApoB100only/LDLR−/− mice which based on lipid profile can be regarde...

Full description

Bibliographic Details
Main Authors:	Ildikó Lantos, Valéria Endrész, Dezső Péter Virok, Andrea Szabó, Xinjie Lu, Tímea Mosolygó, Katalin Burián
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/8325915

Similar Items

<i>Chlamydia pneumoniae</i> Influence on Cytokine Production in Steroid-Resistant and Steroid-Sensitive Asthmatics
by: Dóra Paróczai, et al.
Published: (2020-02-01)

Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.
by: Min Xia, et al.
Published: (2015-01-01)

Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
by: Min Xia, et al.
Published: (2013-01-01)

Beneficial Immunomodulatory Effects of Fluticasone Propionate in <i>Chlamydia pneumoniae</i>-Infected Mice
by: Dóra Paróczai, et al.
Published: (2021-03-01)

Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in human apoB-100 transgenic, LDLr−/− mice
by: Thomas A. Bell, III, et al.
Published: (2007-05-01)

Ambroxol Treatment Suppresses the Proliferation of <i>Chlamydia pneumoniae</i> in Murine Lungs
by: Dávid Kókai, et al.
Published: (2021-04-01)

Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues
by: Dezső P. Virok, et al.
Published: (2019-06-01)

ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage.
by: Carlos Ramírez, et al.
Published: (2011-01-01)

The Opposite Effects of Kynurenic Acid and Different Kynurenic Acid Analogs on Tumor Necrosis Factor-α (TNF-α) Production and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) Expression
by: Yvette Mándi, et al.
Published: (2019-06-01)

Overexpression ofapoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted micethan in apoB-100-only mice
by: Karin Conde-Knape, et al.
Published: (2004-12-01)

The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient “apoB-48-only” and “apoB-100-only” mice
by: Helén L. Dichek, et al.
Published: (2004-03-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr−/− Mice
by: Savitha Subramanian, et al.
Published: (2018-02-01)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
by: Robert Derenbecker, MD, et al.
Published: (2019-10-01)

Correlation between detergent activity and anti-herpes simplex virus-2 activity of commercially available vaginal gels
by: Andrea Szöllősi, et al.
Published: (2020-01-01)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
by: Pontus Dunér, et al.
Published: (2021-04-01)

LDLR and ApoB are Major Genetic Causes of Autosomal Dominant Hypercholesterolemia in a Taiwanese Population
by: Kai-Chien Yang, et al.
Published: (2007-10-01)

Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR−/− apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid1
by: Pascal Degrace, et al.
Published: (2006-12-01)

Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
by: Lakshmi Mundkur, et al.
Published: (2013-01-01)

Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination.
by: D B Zilversmit, et al.
Published: (1989-10-01)

Effects of APOE, APOB and LDLR variants on serum lipids and lack of association with xanthelasma in individuals from Southeastern Brazil
by: Marcelo A. Nakazone, et al.
Published: (2009-01-01)

Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
by: Say-Hean Lye, et al.
Published: (2013-01-01)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
by: Kyung-Yeon Park, et al.
Published: (2016-01-01)

Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice
by: D.M. Grosso, et al.
Published: (2008-12-01)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
by: Aikaterini Arida, et al.
Published: (2021-10-01)

Genetic control of hepatic apoB-100 secretion in human apoB transgenic mouse strains
by: Emanuel Voyiaziakis, et al.
Published: (1999-11-01)

Correction: Immunization of ()-Infected ApobLdlr/J Mice with a Combined Peptide of Significantly Reduces Atherosclerotic Lesion Development.
Published: (2014-01-01)

Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred1
by: L. Haddad, et al.
Published: (1999-06-01)

Chlamydia Pheunomiae and atherosclerosis
by: Arno, Gavin
Published: (2007)

Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice
by: Zsófia Hoyk, et al.
Published: (2018-10-01)

Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele
by: Zhouji Chen, et al.
Published: (2004-01-01)

Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia
by: C. Verseyden, et al.
Published: (2002-02-01)

Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride
by: To Yuen Hui, et al.
Published: (2002-05-01)

The <i>LDLR</i>, <i>APOB</i>, and <i>PCSK9</i> Variants of Index Patients with Familial Hypercholesterolemia in Russia
by: Alexey Meshkov, et al.
Published: (2021-01-01)

Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
by: Bryan T Davis, et al.
Published: (2014-01-01)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice[S]
by: Vladimir R. Babaev, et al.
Published: (2014-11-01)

Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
by: T Demant, et al.
Published: (1993-01-01)

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice
by: Myron E. Hinsdale, et al.
Published: (2002-09-01)

Chlamydia pneumoniae and Atherosclerosis: The End?
by: LE Nicolle
Published: (2005-01-01)

Chlamydia pneumoniae infection and atherosclerosis
by: Smith, Dr David Andrew
Published: (2004)

Cannot write session to /tmp/vufind_sessions/sess_aldoi3cl86qtn22p279pgej26b